Cell specificity of adeno-associated virus (AAV) serotypes in human cortical organoids
Morgan M. StantoniD, Harsh N. HarianiiD, Jordan M. SorokiniD, Patrick M. Taylor, Sara Modan, Brian G. RashiD, Sneha B. RaoiD, Luigi Enriquez, Daphne QuangiD, Pei-Ken HsuiD, Justin H. PaekiD, Dorah Owango, Carlos Castrillo, Justin Nicola, Pavan RamkumariD, Andy Lash, Douglas Flanzer, Kevan D. ShahiD, Saul KatoiD, Gaia Skibinski
Abstract
Human-derived cortical organoids (hCOs) recapitulate cell diversity and 3D structure found in the human brain and offer a promising model for discovery of new gene therapies targeting neurological disorders. Adeno-associated viruses (AAVs) are the most promising vehicles for non-invasive gene delivery to the central nervous system (CNS), but reliable and reproducible in vitro models to assess their clinical potential are lacking. hCOs can take on these issues as they are a physiologically relevant model to assess AAV transduction efficiency, cellular tropism, and biodistribution within the tissue parenchyma, all of which could significantly modulate therapeutic efficacy. Here, we examine a variety of naturally occurring AAV serotypes and measure their ability to transduce neurons and glia in hCOs from multiple donors. We demonstrate cell tropism driven by AAV serotype and hCO donor and quantify fractions of neurons and astrocytes transduced with GFP as well as overall hCO health.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparative analysis of six adeno-associated viral vector serotypes in mouse inferior colliculus and cerebellum
Isabelle F. Witteveen, Timothy S. Balmer·eNeuroPeer-reviewed·Oct 28, 2024
- Comprehensive investigation of AAV tropism across human iPSC-derived neuronal subtypes
Linus Wiora, Salvador Rodrı́guez-Nieto, … Stefan Hauser·bioRxiv·Mar 30, 2026
- Common AAV gene therapy vectors show indiscriminate transduction of living human brain cell types
John P. McGinnis, Joshua Ortiz‐Guzman, … Benjamin Russell Arenkiel·Molecular Therapy — Methods & Clinical DevelopmentPeer-reviewed·May 21, 2025
- Two engineered AAV capsid variants for efficient transduction of human cortical neurons directly converted from iPSC
Sandra Elisabeth Fischer, Benjamin Strobel, … Frank Gillardon·Journal of Neuroscience MethodsPeer-reviewed·Dec 22, 2021
- AAVs Targeting Human Carbonic Anhydrase IV Enhance Gene Delivery to the Brain
Changfan Lin, Xinhong Chen, … Viviana Gradinaru·Cell ReportsPeer-reviewed·Oct 31, 2025
- Optimal AAV capsid/promoter combinations to target specific cell types in the common marmoset cerebral cortex
Yasunori Matsuzaki, Yuuki Fukai, … Hirokazu Hirai·bioRxiv·May 9, 2024